{"name":"Theranexus","slug":"theranexus","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-03-25","type":"pipeline","source":"actusnews.com","summary":"THX Pharma Announces the Publication of its Letter to Shareholders - actusnews.com","headline":"THX Pharma Announces the Publication of its Letter to Shareholders","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-19","type":"pipeline","source":"actusnews.com","summary":"THX Pharma Reports Its Cash Position as of December 31, 2025 - actusnews.com","headline":"THX Pharma Reports Its Cash Position as of December 31, 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxNcjVtZzE2U05mMWs1MlBLeXgyb0tmRUwtcE1VZDhWUGZOQWFiOU9iSlVMem56VFpwZXpoMzVTTVI0SVVYVG9VRVUtaXJzblM1Y3VtbjhYYlkxWW1VeVlud1hwVnZSV2VwcEQ5RkcwZXpqS3dmdFl6UUZiVE1JQXIzTmM0RllUNklFTnc5d3hJN1g5OE9xWng0VThtQVRZM3NQWkpwWE5GbmRnYkp0OGt2VU5weG1GYktQekJwMXh0NTB6UmRobDhCRHdWVdIB0AFBVV95cUxNQ2FDSWl1cEU4ZDM4SG52MDhsQTMwSlRIbk1XR2RoU09DQWROeUZjWWVvejRsT2tsRERhRWpQbTlNV25xX0c5eFJ5WkphYUJIWl9QQWtJNk9TS3dpUUp1RnFjRzZERVM5R2EtT1c0VFJseDItUXdrSENWMERGRFlQcmNfZG1sZUZRM2wyckVSZGxDZzd5dm55TFJGbXJ2bm9teEp1MjlyRmlCc3haYkVlVjJKWmtndlRQRWxpdHJrc2prZ2xCOE9NbUcwb2hxRFRW?oc=5","date":"2026-02-12","type":"pipeline","source":"actusnews.com","summary":"THX Pharma to Host a Webinar to Discuss Its Strategic Agreement with Biocodex - actusnews.com","headline":"THX Pharma to Host a Webinar to Discuss Its Strategic Agreement with Biocodex","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-10","type":"pipeline","source":"actusnews.com","summary":"THX Pharma and Biocodex announce a strategic licensing agreement covering three rare diseases - actusnews.com","headline":"THX Pharma and Biocodex announce a strategic licensing agreement covering three rare diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPOV9NeTJfODluTVNqRU1TTFk4a2lWNkpxODljN3ZfNVJJLTJtcV9FWmJMdHpwbU51Q0FfcnR1LWlqUUFtNXRFeTg5U19nVlNWUjlTRkM2c2daMjFuWF9CT01GWWpiMG5wVzIzR29xZnNpek9QQ0FXTldteGZFU3pUbS1XVWJyajdRS2NSVTZscnFtOUxhdlNHNUM2eTRQMWhpQWFvRHp1Q0J3NkladFRYbWNCSllDa1RsaF9nNw?oc=5","date":"2025-10-23","type":"pipeline","source":"Pharmafile","summary":"THX Pharma and Exeltis announce first milestone achieved for neurological disease treatment - Pharmafile","headline":"THX Pharma and Exeltis announce first milestone achieved for neurological disease treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_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?oc=5","date":"2025-10-23","type":"pipeline","source":"actusnews.com","summary":"THX Pharma announces the launch of a capital increase with preferential subscription rights of nearly EUR 8… - actusnews.com","headline":"THX Pharma announces the launch of a capital increase with preferential subscription rights of nearly EUR 8…","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOYWRvcHNhTnRKQUZrUFpRZnN4S0hIeWJXb0ttRXoxMmJqd2o5OGxlaUtmU2YtNVJZOVRkaDVydlVTSkRFS0I2QTRLT1lyMFJDcWw5TV9Hc2t0bjE5MFhXeEtYVDVXUHlhaGU5TXIxYWtJQ24yUFpMc2ExS01lT0dfOVoweVMwVG5OQ2RFYkRnS1JycTY4aXc?oc=5","date":"2024-12-18","type":"deal","source":"The Pharma Letter","summary":"Theranexus leaps on deal with Exeltis to commercialize TX01 - The Pharma Letter","headline":"Theranexus leaps on deal with Exeltis to commercialize TX01","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxOMjl3VUtqQ0ZJczhiUDkwQ005QzNHeWxONzZuTXE4b013bVZWdmxacWNQbzVnODB0b3I1RGhvWGZLSUJ0RXJuWTJ2WXo3QVJsSEtUUUJGTDdZcmNRcEo0SXI3cVl1emtMNjcwZm5NeEhNeTBaeTFFT3laNDZqYWlGTXFPcEJCcUoyZzRHektsSkIxbWxwR1pYc2k1ZTQySzNwdmFlaklDZnR1Q0U?oc=5","date":"2024-12-18","type":"pipeline","source":"Manufacturing Chemist","summary":"Theranexus and Exeltis sign commercialisation agreement for neurological disorder-targeting TX01 - Manufacturing Chemist","headline":"Theranexus and Exeltis sign commercialisation agreement for neurological disorder-targeting TX01","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}